PFS
VKTX icon

Prospera Financial Services’s Viking Therapeutics VKTX Stock Holding History

Prospera Financial Services’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$382K Buy
9,781
+506
+5% +$16.3K 0.01% 1152
2026
Q1 		$302K Sell
9,275
-90
-1% -$2.89K ﹤0.01% 1202
2025
Q4 		$329K Buy
9,365
+455
+5% +$16.1K 0.01% 1115
2025
Q3 		$234K Buy
+8,910
New +$266K ﹤0.01% 1234
2025
Q1 		– Sell
-5,331
Closed -$215K – 1235
2024
Q4 		$215K Buy
5,331
+624
+13% +$35.6K 0.01% 1061
2024
Q3 		$298K Buy
+4,707
New +$276K 0.01% 923
2024
Q2 		– Sell
-3,565
Closed -$292K – 1188
2024
Q1 		$292K Buy
+3,565
New +$159K 0.01% 910

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Prospera Financial Services's VKTX Position: Q2 2026 in Review

Prospera Financial Services increased its Viking Therapeutics (VKTX) stake by 5.5% in Q2 2026, buying an estimated $16.3K and bringing the position to 9,781 shares worth $382K. The position accounts for 0.01% of the portfolio, ranked #1152.

Prospera Financial Services first reported a position in VKTX in Q1 2024 and has held it in 7 quarters since. 436 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Prospera Financial Services held 9,781 shares of Viking Therapeutics worth $382K as of Q2 2026.
  • Prospera Financial Services bought 506 Viking Therapeutics shares in Q2 2026, an estimated $16.3K.
  • Viking Therapeutics made up 0.01% of Prospera Financial Services's portfolio in Q2 2026, its #1152 holding.
  • Prospera Financial Services first reported a position in Viking Therapeutics in Q1 2024 and has held it in 7 quarters since.
  • 436 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.